The Board proposes the development of rule amendments to address the appropriate standards for the use of controlled substances for the treatment of pain.  


  • RULE NO: RULE TITLE
    64B8-9.013: Standards for the Use of Controlled Substances for the Treatment of Pain
    PURPOSE AND EFFECT: The Board proposes the development of rule amendments to address the appropriate standards for the use of controlled substances for the treatment of pain.
    SUBJECT AREA TO BE ADDRESSED: Appropriate standards for the use of controlled substances for the treatment of pain.
    SPECIFIC AUTHORITY: 458.309(1), 458.331(1)(v) FS.
    LAW IMPLEMENTED: 456.326, 458.331(1)(g), (t), (v) FS.
    IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Larry McPherson, Jr., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

    THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.

Document Information

Subject:
Appropriate standards for the use of controlled substances for the treatment of pain.
Purpose:
The Board proposes the development of rule amendments to address the appropriate standards for the use of controlled substances for the treatment of pain.
Rulemaking Authority:
458.309(1), 458.331(1)(v) FS.
Law:
456.326, 458.331(1)(g), (t), (v) FS.
Contact:
Larry McPherson, Jr., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253
Related Rules: (1)
64B8-9.013. Standards for the Use of Controlled Substances for the Treatment of Pain